Anbio Biotechnology

US$3.89As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:NNNNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 27.05%
Medical Instruments & Supplies
Beta (5Y) —
PE TTM 26.53
TSR TTM (76.91%)
Mkt cap US$170.7M
ROIC 15.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.66
19.82%
(39.52%)
Hold 11|5|12|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.08
0.09
0.08
0.08
20.34%
17.85%
1.08%
(4.50%)
Revenue$M
20.90
21.00
22.11
21.62
1.41%
3.24%
11.15%
7.94%
Peers (US$170.7M)
Cap (US$)
PE
3.366B
23.14x
1.210B
—
104.5M
272.1x
163.1M
26.95x
Capital
TTM
5Y
10Y
Leveragex
6.321
0.088
0.073
EBIT/Intx
0.680
0.219
0.229
Own earn%
544.03
(235.27)
(196.88)
Sh yield%
26.07
38.40
39.91
Owners
Insiders/Inst%
10.15
63.82
Short interest%
2.93
SBC / revenue%
5.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
15–19
$1 testx
0.0
Incr. ROIC%
4